ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.848,77
-0,34%
S&P 500
6.040,04
1,10%
Dow Jones
43.297,03
0,91%
Euro vs US Dollar
1,03952
-0,04%
Bitcoin
98.634,64
-0,67%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. AnaptysBio Inc (ANAB)

  7. AnaptysBio Inc (ANAB) News

ANAB

AnaptysBio (ANAB)

AnaptysBio Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ANAB
DatumZeitQuelleÜberschriftSymbolFirma
18/12/202422h30Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:ANABAnaptysBio Inc
11/12/202422h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANABAnaptysBio Inc
11/12/202414h30GlobeNewswire Inc.Anaptys Announces Phase 2b Trial of ANB032, a BTLA Agonist, Did Not Meet Primary or Secondary Endpoints in Atopic DermatitisNASDAQ:ANABAnaptysBio Inc
18/11/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ANABAnaptysBio Inc
15/11/202422h06Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ANABAnaptysBio Inc
14/11/202415h24Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ANABAnaptysBio Inc
05/11/202422h27Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ANABAnaptysBio Inc
05/11/202422h19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ANABAnaptysBio Inc
05/11/202422h17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANABAnaptysBio Inc
05/11/202422h15GlobeNewswire Inc.Anaptys Announces Third Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:ANABAnaptysBio Inc
05/11/202422h15GlobeNewswire Inc.Anaptys Announces Participation in November and December Investor ConferencesNASDAQ:ANABAnaptysBio Inc
24/09/202422h18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
23/09/202422h16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANABAnaptysBio Inc
18/09/202400h45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
18/09/202400h42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
29/08/202415h15GlobeNewswire Inc.Anaptys Announces Participation in September Investor ConferencesNASDAQ:ANABAnaptysBio Inc
16/08/202422h09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
16/08/202418h07Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:ANABAnaptysBio Inc
16/08/202418h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
14/08/202422h43Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANABAnaptysBio Inc
14/08/202422h41Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ANABAnaptysBio Inc
14/08/202422h34Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANABAnaptysBio Inc
14/08/202411h00GlobeNewswire Inc.Anaptys Announces Pricing of $100 Million Underwritten Registered Direct OfferingNASDAQ:ANABAnaptysBio Inc
05/08/202422h25Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ANABAnaptysBio Inc
05/08/202422h22Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ANABAnaptysBio Inc
05/08/202422h18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANABAnaptysBio Inc
05/08/202422h15GlobeNewswire Inc.Anaptys Announces Second Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:ANABAnaptysBio Inc
24/07/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
24/07/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
20/07/202402h35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
 Showing the most relevant articles for your search:NASDAQ:ANAB

Kürzlich von Ihnen besucht

USOTC
BASFY
BASF (QX)
FX
EURGBP
Euro vs Sterling
NASDAQ
QQQ
Invesco QQQ Trust Series 1
DBI
SDXP
SDAX
TG
BAYN
Bayer
NYSE
XOM
Exxon Mobil
AMEX
SPY
SPDR S&P 500
TG
DTE
Deutsche Telekom
TG
DBK
Deutsche Bank
NASDAQ
NVDA
NVIDIA
NASDAQ
TSLA
Tesla
AMEX
XLF
Financial Select Sector
COIN
SOLUSD
Solana
COIN
DOGEUSD
Dogecoin
CCOM
US30
US 30
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten